Bilypsa is used for Noncirrhotic Non-Alcoholic Steatohepatitis, Type 2 diabetes mellitus, Non-alcoholic fatty liver disease. Know it’s uses, side effects, reviews, composition and precautions only on 1mg. Saroglitazar helps reduce triglyceride levels considerably, total cholesterol, LDL (bad cholesterol), VLDL, and non-HDL-C. It is especially useful in diabetic and atherogenic dyslipidemia. Reduces HbA1c and fasting plasma glucose in type 2 diabetes. Useful in patients who require simultaneous management of glucose and cholesterol levels. Potentially beneficial in lowering hepatic steatosis and fibrosis. Improving cholesterol and glucose levels may minimize overall cardiovascular risk in ... Saroglitazar Mg was launched in India in September 2013, for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type-2 diabetes not controlled by statins alone. In January this year, Saroglitazar Mg received an approval for the treatment of Type 2 Diabetes Mellitus. Saroglitazar treats high triglycerides and diabetic dyslipidemia in type 2 diabetes. Know its uses, dosage, benefits, and possible side effects.
